Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Genetic Visions, Illumina; Aureon Laboratories; Helicos BioSciences; Decode Genetics; Imagenes

NEW YORK (GenomeWeb News) – Genetic Visions said this week that it has completed the Illumina CSPro certification for Infinium Whole-Genome Genotyping. The Middleton, Wis.-based firm said that it underwent a rigorous two-phase certification process including minimum data generation, data certification, and an on-site audit of its facility and processes.


Roche said that the Research Institute of the Hospital Universitari Vall d'Hebron in Barcelona is the first Spanish health center to acquire a 454 Life Sciences Genome Sequencer FLX System.


Aureon Laboratories said this week that results from a peer-reviewed study published in the July 2009 issue of the Journal of Urology demonstrated that the firm's approach of integrating morphometry and biomarker data with clinical information improves accuracy for identifying which patients are most likely to develop prostate cancer progression post-surgery.

The Yonkers, NY-based firm said that its method is twice as effective at identifying patients who are at high risk for disease progression, within eight years, than other currently available tools.


Helicos BioSciences announced that a study demonstrating the accuracy, precision, and sensitivity of its helicos Digital gene Expression application combined with its Genetic Analysis System has been published in this week's issue of Nature Biotechnology.

The study outlines a high-throughput, amplification-free and ligation-free approach to the accurate quantification of the yeast expressed genome using as few as one of the 50 channels of the HeliScope sequencer. (A detailed article on the paper is published in the most recent issue of GenomeWeb Daily News sister publication In Sequence).


Decode Genetics said that researchers from the firm in collaboration with academic colleagues from Europe and the US have discovered common genetic risk factors for basal cell carcinoma that affect people with fair and dark complexions alike. Their findings are presented in a study in the journal Nature Genetics this week.


Imagenes said this week that it will provide the microarray-based analysis of diet-related modifications (histone modifications) of gene activity in several organisms, including humans, as part of the "Vision Epifood" project, which is examining the epigenetic effects of nutrition on human health.

In addition to microarray design, Imagenes said that it will provide data analysis and integration. The German Federal Ministry for Education and Research is funding the project with €2.9 million (US$4 million) over four years.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.